Pharmaceutical Business Review
Return to: PBR Home
Top Headlines

Pharmaceutical Business Review

Evotec and Celgene partner to develop oncology treatments Germany-based drug discovery firm Evotec has partnered with American biotechnology company Celgene to identify new therapeutics in oncology with an initial focus on solid tumors. Drug Research > Drug Discovery & Development > News
Takeda to sell Techpool to Chinese JV partners Takeda Pharmaceutical has agreed to divest its its majority shareholding of 51.34% in Guangdong Techpool Bio-Pharma (Techpool), a China-based firm focused on urinary protein biopharmaceuticals and production of biopharmaceuticals in critical care, to its joint venture (JV) partners for $280m.
Production & Manufacturing > Manufacturing > News FDA to review Zynquista as potential treatment for type 1 diabetes The US Food and Drug Administration (FDA) has accepted Sanofi's regulatory filing for Zynquista (sotagliflozin).
Regulatory Affairs > News WuXi Biologics to establish $60m biologics manufacturing facility in Singapore By PBR Staff Writer
Chinese firm WuXi Biologics has announced a S$80m ($60m) investment to set up an a biologics manufacturing facility in Singapore.
Production & Manufacturing > Manufacturing > News
Evotec and Celgene partner to develop oncology treatments By PBR Staff Writer
Germany-based drug discovery firm Evotec has partnered with American biotechnology company Celgene to identify new therapeutics in oncology with an initial focus on solid tumors.
Drug Research > Drug Discovery & Development > News Alivio Therapeutics secures two US patents for inflammation-targeting technology platform Alivio Therapeutics, an affiliate of PureTech Health, announced that the US Patent and Trademark Office (USPTO) issued U.S. Patent Nos. 9,962,339 and 9,974,859, related to its inflammation-targeting technology platform.
Drug Research > Drug Discovery & Development > News ViiV Healthcare gets EC approval for Juluca to treat HIV-1 infection By PBR Staff Writer
ViiV Healthcare, a joint venture of GlaxoSmithKline (GSK), Pfizer and Shionogi, has secured marketing approval from the European Commission (EC) for Juluca (dolutegravir 50mg/rilpivirine 25mg) to treat human immunodeficiency virus type 1 (HIV-1) infection.
Regulatory Affairs > News

Latest News and Insight by Sector

Production & Manufacturing

Takeda to sell Techpool to Chinese JV partners
Takeda Pharmaceutical has agreed to divest its its majority shareholding of 51.34% in Guangdong Techpool Bio-Pharma (Techpool), a China-based firm focused on urinary protein biopharmaceuticals and production of biopharmaceuticals in critical care, to its joint venture (JV) partners for $280m.
Production & Manufacturing > Manufacturing > News
WuXi Biologics to establish $60m biologics manufacturing facility in Singapore
By PBR Staff Writer
Chinese firm WuXi Biologics has announced a S$80m ($60m) investment to set up an a biologics manufacturing facility in Singapore.
Production & Manufacturing > Manufacturing > News

Drug Research

Evotec and Celgene partner to develop oncology treatments
By PBR Staff Writer
Germany-based drug discovery firm Evotec has partnered with American biotechnology company Celgene to identify new therapeutics in oncology with an initial focus on solid tumors.
Drug Research > Drug Discovery & Development > News
Alivio Therapeutics secures two US patents for inflammation-targeting technology platform
Alivio Therapeutics, an affiliate of PureTech Health, announced that the US Patent and Trademark Office (USPTO) issued U.S. Patent Nos. 9,962,339 and 9,974,859, related to its inflammation-targeting technology platform.
Drug Research > Drug Discovery & Development > News

Inward Investment

New WuXi Life Science to acquire WuXi PharmaTech for $3.3bn
Shanghai-based WuXi PharmaTech has entered into a merger agreement with New WuXi Life Science and its wholly owned subsidiary WuXi Merger, worth a total cash consideration of $3.3bn.
Inward Investment > News
PPF Group acquires minority stake in Cytune Pharma
By PBR Staff Writer
PPF Group, in cooperation with SOTIO has completed acquisition of minority stake in French biotechnology firm Cytune Pharma.
Inward Investment > News

Packaging

Catalent completes acquisition of Australia's Pharmapak
By PBR Staff Writer
US-based Catalent Pharma Solutions has strengthened its ability to provide integrated solutions to customers with the acquisition of Pharmapak Technologies, an Australian pharmaceutical packaging business.
Production & Manufacturing > OTC > News
MP Global Products introduces foam-free packaging for shipment of temperature sensitive pharmaceuticals
MP Global Thermal Packaging Products insulated protective mailers and box liners are specifically designed for temperature control and protection of mail order shipments of temperature sensitive pharma, pet meds, and natural and organic cosmetics.
Packaging > News

Contract Research & Services

Midatech begins dosing in first human trial of cancer drug Q-Octreotide
Midatech has commenced initial dosing in the first in-human study of its sustained release product Q-Octreotide (MTD201) for the treatment of carcinoid cancer and acromegaly.
Contract Research & Services > Clinical Trials > News
Janssen's Erleada shown to reduce PSA progression by 94% in nmCRPC patients
By PBR Staff Writer
Janssen Pharmaceutical's androgen receptor inhibitor Erleada (apalutamide) succeeded in a phase 3 trial by significantly cutting down the risk of prostate specific antigen (PSA) progression in patients having non-metastatic castration-resistant prostate cancer (nmCRPC).
Contract Research & Services > Clinical Trials > News

Automation

Horizon Discovery out-licenses cell line engineering technology to US firm
Horizon Discovery Group has entered into a non-exclusive out-licensing agreement with an undisclosed US-based immuno-oncology company (the Partner) for its technologies to support the development and manufacture of a biomanufacturing cell line for commercial use.
Automation > IT & Software > News
GE to provide biomanufacturing platform for Clover’s Chinese facility
By PBR Staff Writer
GE Healthcare will provide its biomanufacturing platform for Clover Biopharmaceuticals’ new production facility in China.
Automation > IT & Software > News

Regulatory Affairs

FDA to review Zynquista as potential treatment for type 1 diabetes
The US Food and Drug Administration (FDA) has accepted Sanofi's regulatory filing for Zynquista (sotagliflozin).
Regulatory Affairs > News
ViiV Healthcare gets EC approval for Juluca to treat HIV-1 infection
By PBR Staff Writer
ViiV Healthcare, a joint venture of GlaxoSmithKline (GSK), Pfizer and Shionogi, has secured marketing approval from the European Commission (EC) for Juluca (dolutegravir 50mg/rilpivirine 25mg) to treat human immunodeficiency virus type 1 (HIV-1) infection.
Regulatory Affairs > News



Data-Label.co.uk DataLabel have been supplying
the medical industry with labels
for over 10 years

Manufactures of
healthcare packaging
machinery